| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |